Due to misinformation about using cannabidiol oil for pain relief, we feel it is important to provide accurate information about CBDs as they relate to ONE13. CBD is a cannabinoid with therapeutic qualities that be extracted from two different varieties of the hemp plant. In studying the plant, researchers found at least 113 phytochemical compounds that are collectively called cannabinoids. CBD does not have any psychoactive properties, meaning that cannabidiol oil does not either. More importantly, clinical studies show that CBD may have extensive therapeutic applications, probably more so than any other cannabinoid.
Research indicates that CBD activates endocannabinoid receptors type 1 and type 2 (CB1, CB2) to induce analgesia to the brain from the spinal column, preventing mast cell degranulation and inhibiting the production of pro-inflammatory gene transcripts. While CBD products can be prepared in many fashions, ONE13 has been scientifically formulated and prepared for topical application, allowing you to seamlessly work ONE13 into your patients’ care while avoiding the stigma of pills.